Exploring the Role of DICER1 Mutations in Ovarian Sex Cord-Stromal Tumors: A Retrospective Analysis and Implications for Surveillance

Main Article Content

Ülkü Miray Yıldırım
Doğa Dalay
Ozlem Dural
Ismail Yilmaz
Neslihan Karakurt
Egemen Eroğlu
Semen Önder
Kris Ann P. Schultz
Rejin Kebudi


Objective: Ovarian sex cord-stromal tumors (OSCSTs) are a rare and heterogeneous group, accounting for less than 1% of all malignancies and about 10% of ovarian tumors in childhood and adolescence. Some OSCSTs have been associated with germline pathogenic DICER1 variations. This study aims to determine the incidence of DICER1 pathogenic variations in a small cohort of OSCSTs and evaluate the clinicopathological features and patient outcomes.

Material and Methods: We retrospectively reviewed the medical records of the patients diagnosed with OSCSTs between 2014-2021. Molecular genetic sequencing of the tumor samples to detect a RNase IIIb domain hot spot mutation in DICER1 was performed in five patients.

Results: Molecular genetic sequencing of the tumor samples revealed a DICER1 gene mutation in exon 27 c.5437G>C (p.E1813Q) in a patient with Sertoli-Leydig cell tumour. 

Conclusions: Although our study included a small number of patients, our findings highlight the importance of knowing the possible association between OSCSTs and pathogenic germline DICER1 variants since detecting this mutation may provide the opportunity for surveillance of related conditions that could improve long-term outcomes and survival, and also enable screening of family members.


Download data is not yet available.

Article Details

How to Cite
Yıldırım, Ülkü M., Dalay, D., Dural, O. ., Yilmaz, I. ., Karakurt, N. ., Eroğlu, E., Önder, S. ., Schultz , K. A. P. ., & Kebudi, R. (2023). Exploring the Role of DICER1 Mutations in Ovarian Sex Cord-Stromal Tumors: A Retrospective Analysis and Implications for Surveillance. Medical Science and Discovery, 10(10), 788–791. https://doi.org/10.36472/msd.v10i10.1048
Research Article
Received 2023-09-22
Accepted 2023-10-02
Published 2023-10-08


Schneider D, Terenziani M, Cecchetto G, Olson T. Gonadal and Extragonadal Germ Cell Tumors, Sex Cord Stromal and Rare Gonadal Tumors. 2012. p. 327-402. DOI: https://doi.org/10.1007/978-3-642-04197-6_39

Schultz KA, Schneider DT, Pashankar F, Ross J, Frazier L. Management of ovarian and testicular sex cord-stromal tumors in children and adolescents. J Pediatr Hematol Oncol. 2012;34 Suppl 2:S55-63. DOI: https://doi.org/10.1097/MPH.0b013e31824e3867

Karnezis AN, Wang Y, Keul J, Tessier-Cloutier B, Magrill J, Kommoss S, et al. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors. Am J Surg Pathol. 2019;43(5):628-38. DOI: https://doi.org/10.1097/PAS.0000000000001232

Wang Y, Karnezis AN, Magrill J, Tessier-Cloutier B, Lum A, Senz J, et al. DICER1 hot-spot mutations in ovarian gynandroblastoma. Histopathology. 2018;73(2):306-13. DOI: https://doi.org/10.1111/his.13630

Onder S, Hurdogan O, Bayram A, Yilmaz I, Sozen H, Yavuz E. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary. Virchows Archiv. 2021;479(2):317-24. DOI: https://doi.org/10.1007/s00428-021-03052-2

Pecorelli S, Benedet JL, Creasman WT, Shepherd JH, Oncology obotFCoG. FIGO staging of gynecologic cancer. International Journal of Gynecology & Obstetrics. 1999;64(1):5-10. DOI: https://doi.org/10.1016/S0020-7292(98)00234-3

Kurman RJCMLHSYRH. WHO classification of tumours of female reproductive organs. Lyon: IARC; 2014.

Rio Frio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, Sabbaghian N, et al. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA. 2011;305(1):68-77. DOI: https://doi.org/10.1001/jama.2010.1910

Schultz KA, Pacheco MC, Yang J, Williams GM, Messinger Y, Hill DA, et al. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol. 2011;122(2):246-50. DOI: https://doi.org/10.1016/j.ygyno.2011.03.024

Lim D, Oliva E. Ovarian sex cord-stromal tumours: an update in recent molecular advances. Pathology. 2018;50(2):178-89. DOI: https://doi.org/10.1016/j.pathol.2017.10.008

de Kock L, Terzic T, McCluggage WG, Stewart CJR, Shaw P, Foulkes WD, et al. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. Am J Surg Pathol. 2017;41(9):1178-87. DOI: https://doi.org/10.1097/PAS.0000000000000895

Goulvent T, Ray-Coquard I, Borel S, Haddad V, Devouassoux-Shisheboran M, Vacher-Lavenu MC, et al. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Histopathology. 2016;68(2):279-85. DOI: https://doi.org/10.1111/his.12747

Kato N, Kusumi T, Kamataki A, Tsunoda R, Fukase M, Kurose A. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects. Hum Pathol. 2017;59:41-7. DOI: https://doi.org/10.1016/j.humpath.2016.09.005

Han LM, Weiel JJ, Longacre TA, Folkins AK. DICER1-associated Tumors in the Female Genital Tract: Molecular Basis, Clinicopathologic Features, and Differential Diagnosis. Advances in Anatomic Pathology. 2022;29(5):297-308. DOI: https://doi.org/10.1097/PAP.0000000000000351

Heravi-Moussavi A, Anglesio MS, Cheng SW, Senz J, Yang W, Prentice L, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 2012;366(3):234-42. DOI: https://doi.org/10.1056/NEJMoa1102903

Hill DA, Ivanovich J, Priest JR, Gurnett CA, Dehner LP, Desruisseau D, et al. DICER1 mutations in familial pleuropulmonary blastoma. Science. 2009;325(5943):965. DOI: https://doi.org/10.1126/science.1174334

Robertson JC, Jorcyk CL, Oxford JT. DICER1 Syndrome: DICER1 Mutations in Rare Cancers. Cancers (Basel). 2018;10(5). DOI: https://doi.org/10.3390/cancers10050143

Kebudi R, Dural O, Bay SB, Gorgun O, Onder S, Bilgic B, et al. Childhood Rhabdomyosarcoma of the Female Genital Tract: Association with Pathogenic DICER1 Variation, Clinicopathological Features, and Outcomes. Journal of Pediatric and Adolescent Gynecology. 2021;34(4):449-53. DOI: https://doi.org/10.1016/j.jpag.2021.01.011

Hurdogan O, Yilmaz I, Bay SB, Vural S, Tugcu D, Kebudi R, et al. DICER1 Hotspot Mutations in Pleuropulmonary Blastoma: A Case Series From a Tertiary Center. Pediatr Dev Pathol. 2020;23(3):204-9. DOI: https://doi.org/10.1177/1093526619878602

Dural O, Kebudi R, Yavuz E, Yilmaz I, Buyukkapu Bay S, Schultz KAP, et al. DICER1-Related Embryonal Rhabdomyosarcoma of the Uterine Corpus in a Prepubertal Girl. J Pediatr Adolesc Gynecol. 2020;33(2):173-6. DOI: https://doi.org/10.1016/j.jpag.2019.12.002

Stewart DR, Best AF, Williams GM, Harney LA, Carr AG, Harris AK, et al. Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1. J Clin Oncol. 2019;37(8):668-76. DOI: https://doi.org/10.1200/JCO.2018.78.4678

Foulkes WD, Priest JR, Duchaine TF. DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer. 2014;14(10):662-72. DOI: https://doi.org/10.1038/nrc3802

Baillard P, Genestie C, Croce S, Descotes F, Rouleau E, Treilleux I, et al. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors. The American Journal of Surgical Pathology. 2021;45(2):223-9. DOI: https://doi.org/10.1097/PAS.0000000000001582

Conlon N, Schultheis AM, Piscuoglio S, Silva A, Guerra E, Tornos C, et al. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors. Mod Pathol. 2015;28(12):1603-12. DOI: https://doi.org/10.1038/modpathol.2015.115